Mike Doustdar, who will take office on August 7, is currently Novo Nordisk’s Executive Vice President of International Operations. Under his leadership, this division has more than doubled its sales over the past decade, reaching nearly 112 billion Danish kroner last year.
"We are confident that he is the best person to lead Novo Nordisk through i...
Novo Nordisk appoints Mike Doustdar as new CEO
The Danish pharmaceutical giant Novo Nordisk has appointed Mike Doustdar as its new CEO. At the same time, the company announced it was lowering its forecasts – which caused the stock to drop sharply on Wednesday.
Mike Doustdar, CEO Novo Nordisk Photo: Novo Nordisk
Vill du få åtkomst till allt?
Prova 30 dagar för 0 kr.
Inga bindningstider eller kortuppgifter krävs.
Prova nu
Köp en prenumeration
Utforska våra prenumerationslösningar och välj den som passar dina behov.
Välj din prenumeration